US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jan 26, 2022 (5 years ago)

Cystex Tablet (Sodium Salicylate 162.5 mg, Methenamine 162 mg) Bulk Container, ULTRAtab…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations

What was recalled

Cystex Tablet (Sodium Salicylate 162.5 mg, Methenamine 162 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY 62959-945-00

Recalling firm
ULTRAtab Laboratories, Inc.
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0555-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Methenamine recalls

See all